GlassScriptPhysician profile
Vishal Verma
NPI 1316131865
$159,240.92
in general payments reported to CMS, 2019-2025
7 companies · $7,083 in 2025
The $7,083 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $514 · 2021: $156 · 2022: $133K · 2023: $6,094 · 2024: $12K · 2025: $7,083.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21K · Travel and Lodging: $2,305 · Food and Beverage: $2,290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,075.00 |
| Travel and Lodging | $2,304.86 |
| Food and Beverage | $2,290.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $132,576.47 | 2019-2022 | |
| Alcon Vision LLC | $26,122.52 | 2019-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Johnson & Johnson Surgical Vision, INC. | $315.84 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Microsurgical Technology, INC. | $103.39 | 2024 | |
| Bausch & Lomb Americas INC. | $59.82 | 2023 | Lotemax Sm, Prolensa, Envista Mx60 Iol |
| Rxsight INC | $44.48 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Abbvie INC. | $18.40 | 2023 | Durysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Verma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.